Authors:
Lundback, B
Ronmark, E
Jonsson, E
Larsson, K
Sandstrom, T
Citation: B. Lundback et al., Incidence of physician-diagnosed asthma in adults - a real incidence or a result of increased awareness? Report from the Obstructive Lung Disease in Northern Sweden Studies, RESP MED, 95(8), 2001, pp. 685-692
Authors:
Larsson, LG
Lindberg, A
Franklin, KA
Lundback, B
Citation: Lg. Larsson et al., Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population, RESP MED, 95(5), 2001, pp. 423-429
Authors:
Hasselgren, M
Arne, M
Lindahl, A
Janson, S
Lundback, B
Citation: M. Hasselgren et al., Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care, SC J PRIM H, 19(1), 2001, pp. 54-57
Authors:
Ronmark, E
Jonsson, E
Platts-Mills, T
Lundback, B
Citation: E. Ronmark et al., Incidence and remission of asthma in schoolchildren: Report from the obstructive lung disease in northern Sweden studies, PEDIATRICS, 107(3), 2001, pp. NIL_52-NIL_58
Authors:
Larsson, LG
Lindberg, A
Franklin, KA
Lundback, B
Citation: Lg. Larsson et al., Obstructive sleep apnoea syndrome is common in subjects with chronic bronchitis - Report from the obstructive lung disease in Northern Sweden studies, RESPIRATION, 68(3), 2001, pp. 250-255
Authors:
Larsson, ML
Frisk, M
Hallstrom, J
Kiviloog, J
Lundback, B
Citation: Ml. Larsson et al., Environmental tobacco smoke exposure during childhood is associated with increased prevalence of asthma in adults, CHEST, 120(3), 2001, pp. 711-717
Authors:
Perruchoud, AP
Lundback, B
Yigla, M
Sykes, AP
Citation: Ap. Perruchoud et al., Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma, RESP MED, 94, 2000, pp. S35-S41
Authors:
Jenkins, C
Woolcock, AJ
Saarelainen, P
Lundback, B
James, MH
Citation: C. Jenkins et al., Salmeterol/fluticasone propionate combination therapy 50/250 mu g twice daily is more effective than budesonide 800 mu g twice daily in treating moderate to severe asthma, RESP MED, 94(7), 2000, pp. 715-723
Authors:
Lundback, B
Jenkins, C
Price, MJ
Thwaites, RMA
Citation: B. Lundback et al., Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 mu g twice daily and budesonide 800 mu g twice daily in the treatment of adults and adolescents with asthma, RESP MED, 94(7), 2000, pp. 724-732
Authors:
Ringdal, N
Lundback, B
Alton, M
Rak, S
Eivindson, A
Bratten, G
Kjaersgaard, P
Citation: N. Ringdal et al., Comparable effects of inhaled fluticasone propionate and budesonide on theHPA-axis in adult asthmatic patients, RESP MED, 94(5), 2000, pp. 482-489
Authors:
Bousquet, J
D'Urzo, A
Hebert, J
Barraza, CH
Boulet, LP
Suarez-Chacon, R
Harnest, U
Lundback, B
Morales, GM
Nieminen, MM
Nolop, KB
Visser, S
Lutsky, BN
Citation: J. Bousquet et al., Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler (R), EUR RESP J, 16(5), 2000, pp. 808-816
Authors:
Montnemery, P
Lanke, J
Lindholm, LH
Lundback, B
Nyberg, P
Adelroth, E
Lofdahl, CG
Citation: P. Montnemery et al., Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey, EUR J EPID, 16(11), 2000, pp. 1003-1007
Authors:
Rudell, B
Blomberg, A
Helleday, R
Ledin, MC
Lundback, B
Stjernberg, N
Horstedt, P
Sandstrom, T
Citation: B. Rudell et al., Bronchoalveolar inflammation after exposure to diesel exhaust: comparison between unfiltered and particle trap filtered exhaust, OCC ENVIR M, 56(8), 1999, pp. 527-534
Authors:
Lundback, B
Pieters, WR
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
Citation: B. Lundback et al., Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma I: Introduction and overview, PHARMACOECO, 16, 1999, pp. 1-8
Authors:
Pieters, WR
Lundback, B
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
Yan, SK
Citation: Wr. Pieters et al., Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II: Study methodologies, PHARMACOECO, 16, 1999, pp. 9-14
Authors:
Pieters, WR
Lundback, B
Sondhi, S
Price, MJ
Thwaites, RMA
Citation: Wr. Pieters et al., Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/500 mug vs fluticasone propionate 500 mu g in patients with corticosteroid-dependent asthma V: Results, PHARMACOECO, 16, 1999, pp. 29-34
Authors:
Wallin, A
Sandstrom, T
Soderberg, M
Howarth, P
Lundback, B
Della-Cioppa, G
Wilson, S
Judd, M
Djukanovic, R
Holgate, S
Lindberg, A
Larssen, L
Citation: A. Wallin et al., The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma, AM J R CRIT, 159(1), 1999, pp. 79-86
Authors:
Pallasaho, P
Lundback, B
Laspa, SL
Jonsson, E
Kotaniemi, J
Sovijarvi, ARA
Laitinen, LA
Citation: P. Pallasaho et al., Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study, RESP MED, 93(11), 1999, pp. 798-809
Authors:
Ronmark, E
Jonsson, E
Platts-Mills, T
Lundback, B
Citation: E. Ronmark et al., Different pattern of risk factors for atopic and nonatopic asthma among children - report from the Obstructive Lung Disease in Northern Sweden Study, ALLERGY, 54(9), 1999, pp. 926-935
Authors:
Perzanowski, MS
Ronmark, E
Nold, B
Lundback, B
Platts-Mills, TAE
Citation: Ms. Perzanowski et al., Relevance of allergens from cats and dogs to asthma in the northernmost province of Sweden: Schools as a major site of exposure, J ALLERG CL, 103(6), 1999, pp. 1018-1024